Two small chromosomal DNA fragments (2.6 and 4.8kb) from the blasticidin S producer Streptomyces griseochromogenes were cloned in the high copy number vector pIJ702 and shown to confer increased resistance to blasticidin S upon S. lividans TK24. These fragments were used to screen a library of S. griseochromogenes DNA prepared in the cosmid shuttle vector pOJ446. Cosmids containing DNA inserts of at least 23kb were identified which hybridized to one or the other resistance fragment, but not to both. Blasticidin S (BS, 1) was first isolated from Streptomyces griseochromogenes1) as part of an effort to replace mercury-based fungicides for prevention of Piricularia oryzae infection of rice plants in Japan2). Blasticidin S is a peptidyl nucleoside derived from the primary precursors cytosine, glucose, arginine and methionine3). The (CGA, 2)5), and cytosinine6) in the pathway has also been demonstrated (Scheme 1). More recently, cytosylglucuronic acid synthase, the enzyme catalyzing the first step in blasticidin biosynthesis and the first prokaryotic UDP-glucuronosyl transferase identified, has been purified and characterized7). of a large family of antibiotics, the nucleosides,9) of which only the biosynthetic genes for puromycin10) and nikkomycin11) have been cloned. Our strategy for cloning the biosynthetic pathway for blasticidin S was first to identify the resistance genes. Because resistance genes in antibiotic-producing prokaryotic organisms are generally located with the biosynthetic genes12), these markers can often be used as probes for the DNA of the biosynthetic cluster. We report here the identification of two small fragments of DNA from S. griseochromogenes which confer increased resistance to blasticidin S upon S. lividans. These resistance fragments were further used to clone larger DNA fragments which, when expressed in S. lividans, result in the production of CGA (2) and other blasticidin S-related metabolites.
Materials and Methods

Bacterial Strains and Plasmids
The blasticidin S producer Streptomyces griseochromogenes was obtained from Dr. Y. MIYAZAKI (Kaken Chemical Co., Ltd., Chiba, Japan) and maintained as previously described7). Streptomyces lividans TK24 and plasmid pIJ702 were obtained from Prof. D. A. HOWOOD (John Innes Inst., Norwich). Streptomyces cultures were grown in either YEME medium13) or GPS medium14) and manipulated by standard procedures13)• E. coli-Streptomyces shuttle cosmid pOJ446, obtained from Lilly Research Laboratories, was used for constructing a S. griseochromogenes chromosomal DNA library15)• The E. coli cloning vector pGEM3Z(+) and E. coli strain JM109 were purchased from Promega Corp.
(Madison, WI) and used in all subcloning experiments. The E. coli vector pBluescript II KS(+) was obtained from Stratagene (La Jolla, CA). All E. coli manipulations were performed according to standard protocols16). for seven days and then screened for metabolite production using ion exchange HPLC coupled with photodiode array detection. Controls for the experiment included S. lividans TK24 alone and transformed with the cosmid vector without insert. One cosmid clone of the 4.8kb-hybridizing group (cos9) was found to produce cytosylglucuronic acid (CGA) in GPS medium. The identity of the metabolite was suggested by comparison of the retention time and UV/vis spectrum with those of authentic CGA (Fig. 1) used to transform S. lividans TK24 and the cultures were screened for expression of the BS biosynthetic genes. Three more cosmid clones (cos 12, cos 14 and cos 16) were identified which produced CGA. None of the clones hybridizing with the 2.6kb resistance fragment produced CGA. Further testing of the clones positive for CGA pron duction led to the detection of additional blasticidin S-related metabolites. The production of these metabolites was lower but more reproducible when the clones were grown in YEME medium, a standard medium for the culture of S. lividans. In YEME medium, S, griseochromogenes produced a large amount of two late-eluting metabolites (blasticidin S and demethylblasticidin S), whereas the transformants produced CGA and a complex of five late-eluting metabolites ( Fig. 2A  and 2B ). These closely-eluting metabolites contain a chromophore closely matching that of blasticidin S not shown). Careful coinjection experiments indicated that metabolite 5 is most probably demethylblasticidin In an attempt to improve the level and stability of BS metabolite production in S. lividans TK24, we sought to simultaneously express both resistance genes. A double transformation experiment was performed with cos9 and the 2.6kb resistance fragment inserted in pIJ702. The transformation frequency with both constructs was one tenth that of either alone. Controls for the experiment included transformation using both vectors with no insert. Four colonies were identified that were resistant to both apramycin (marker for cos9) and thiostrepton Fragment size was determined by reference to a 1 kb DNA ladder (GIBCO BRL). Fragments < 1 kb are not shown.
(marker for pIJ702). Of these four, only one (DT1) produced blasticidin-related metabolites. This culture initially grew very slowly but on continued subculture grew more rapidly in the presence of both antibiotics. Levels of production of the five metabolites of the blasticidin complex by the double transformant and the cos9 clone are compared in Table 1. changed in the double transformant. However, levels of metabolite 4 (tentatively assigned as blasticidin S) and metabolite 5 (demethylblasticidin S) were threefold and 12.5-fold higher, respectively, in the double transformant.
Characteristics
of Cosmid DNA
The reason for lack of metabolite production by three of the four initial isolates in the double transformation experiments was not explored further. However, the cosmids in these strains may have undergone some rearrangements or deletions. We have detected this type of rearrangement in some of the cosmids which initially hybridized with the 4.8kb probe. These cosmids at first showed BamHI restriction patterns similar to the 4.8kb hybridizing cosmids depicted in Figure 3 but on subculture the restriction patterns were drastically altered and their transformants produced no blasticidin-related metabolites (data not shown). However, the BamHI maps in Figure 3 show that fragments of 1.7 and 3.8kb are found in cos4 and most of the cosmids carrying the BS biosynthetic genes. These fragments are candidates for overlap of the 2.6kb and 4.8kb hybridizing cosmids and may be useful in future studies to investigate the proximity of both resistance genes to the biosynthetic cluster and to one another.
We are also interested in the mechanism of BS selfresistance in S. griseochromogenes. Additional restriction mapping performed on the 4.8kb resistance fragment is presented in Figure 4 , and the subcloning and sequencing of this DNA fragment are underway. activity is present in S. griseochromogenes the activity is not detectable in S. lividans carrying either cosmid 9 or the 4.8kb resistance fragment in pIJ702 (ZHANG and ZABRISKIE, unpublished results). Another modified blasticidin produced by S. griseochromogenes is leucylblasticidin, which can accumulate under certain physiological conditions and can be converted to blasticidin 522). Efforts to firmly identify all the BS-related compounds produced by the transformants are continuing and should provide valuable insight into the biosynthesis of BS and its self resistance mechanism. The blasticidin S biosynthetic gene cluster is currently being mapped and sequenced, and further studies will determine if cosmids containing the 2.6kb resistance fragment overlap with those containing the 4.8kb resistance fragment. The major focus is to identify the product of the resistance gene on the 4.8kb DNA fragment and determine its function, as well as to express and characterize other individual genes and their products in the blasticidin S biosynthetic cluster.
